CompletedNot Applicable

A Study on the Relationship Between Gastric Xanthoma and Gastric Cancer and Precancerous Lesions

China1,260 participantsStarted 2022-09-01

Plain-language summary

To explore the effects of gastric xanthoma on gastric cancer and its precancerous lesions, so as to better prevent the occurrence and development of gastric cancer.

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age range from 18 to 75 years old, regardless of gender;
✓. Endoscopic/pathological diagnosis: chronic non atrophic gastritis/chronic atrophic gastritis/intestinal metaplasia/dysplasia Hyperplasia/gastric cancer
✓. Voluntarily sign an informed consent form.

Exclusion criteria

✕. Previously underwent upper gastrointestinal surgery
✕. Previous diagnosis of malignant tumors
✕. Individuals who are unable to cooperate with the questionnaire survey due to mental disorders or other reasons
✕. Those who cannot be observed by endoscopy due to acute upper gastrointestinal bleeding or other reasons

What they're measuring

corelation between the gastric xanthoma and gastric mucosa diseases

Timeframe: up to 6 months

Trial details

NCT IDNCT06282484

SponsorXijing Hospital of Digestive Diseases

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-06-01

View on ClinicalTrials.gov More Gastric Xanthoma trials